Topotecan Hydrochloride Chemical Structure (Hycamtin Spl Graphic 01)
Hycamtin Capsule
Product Images NDC 66758-101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hycamtin (NDC 66758-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1. Kaplan-meier Curves For Overall Survival In Small Cell Lung Cancer In Study 478 (Hycamtin Spl Graphic 02)
This is a statistical analysis presenting survival rates of two groups receiving different treatments. One group received Oral Hycamtin with Best Supportive Care (BSC) and the other group received only BSC. The graph displays the cumulative proportion alive over a period of 48 months. The results indicate the survival rates for each group at different time points. The study involved 70 participants in the BSC only group and 71 participants in the Oral Hycamtin + BSC group. Time in months is shown on the x-axis, with survival rates on the y-axis. The text also mentions that BSC stands for Best Supportive Care.*
Onemgcarton (Onemgcarton)
Point25mgcarton (Point25mgcarton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
